Superparamagnetic agents: physicochemical characteristics and preclinical imaging evaluation.
Benderbous
S
S
Recherche et Developpement Laboratoire Guerbet, Aulnay-sous-Bois, France.
Corot
C
C
Jacobs
P
P
Bonnemain
B
B
D000818:Animals; D001812:Blood-Brain Barrier / Q000502:physiology; D001921:Brain / Q000473:pathology; D001932:Brain Neoplasms / Q000175:diagnosis; D002199:Capillary Permeability; D003287:Contrast Media / Q000008:administration & dosage / Q000737:chemistry* / Q000633:toxicity; D003911:Dextrans; D052203:Ferrosoferric Oxide; D005910:Glioma / Q000175:diagnosis; D006801:Humans; D007501:Iron / Q000737:chemistry* / Q000633:toxicity; D008279:Magnetic Resonance Imaging; D058185:Magnetite Nanoparticles; D008422:Materials Testing; D008657:Metabolic Clearance Rate; D009368:Neoplasm Transplantation; D010087:Oxides / Q000737:chemistry* / Q000633:toxicity; D010316:Particle Size; D051381:Rats; D013329:Structure-Activity Relationship; D014018:Tissue Distribution
D003287:Contrast Media; D003911:Dextrans; D058185:Magnetite Nanoparticles; D010087:Oxides; C097921:ferumoxtran-10; D007501:Iron; D052203:Ferrosoferric Oxide